Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Muga

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Medicina Clinica|February 6, 1993
[Dyslipemia and HIV-1 infection in intravenous drug addicts]R Muga, J Tor, C Rey-Joly, et al.
Medicina Clinica|July 8, 1999
[Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy]R Muga, J M Egea, M Navío, et al.
Medicina Clinica|September 9, 1989
[Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona]V Soriano, J Tor, A Ribera, et al.
Journal of Viral Hepatitis|August 19, 2014
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patientsD Fuster, A Sanvisens, F Bolao, et al.
Medicina Clinica|March 18, 1995
[Tumor necrosis factor-alpha in human immunodeficiency virus infection]P Llobet, R Muga, J A González, et al.
Current HIV Research|December 29, 2010
Use of highly active antiretroviral therapy is increasing in HIV positive severe drug usersG Vallecillo, A Sanvisens, E Martinez, et al.
Current HIV Research|June 17, 2011
Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug usersA Sanvisens, D Fuster, I Serra, et al.
Medicina Clinica|February 11, 1989
[Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia]V Soriano, J Tor, R Muga, et al.
Medicina Clinica|November 5, 1994
[HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993]R Muga, J M Egea, J Tor, et al.
Medicina Clinica|March 31, 1990
[Primary infection caused by human immunodeficiency virus: clinical and serologic aspects of 7 cases]V Soriano, J Tor, R Muga, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Medicina Clinica|February 6, 1993
[Dyslipemia and HIV-1 infection in intravenous drug addicts]R Muga, J Tor, C Rey-Joly, et al.
Medicina Clinica|July 8, 1999
[Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy]R Muga, J M Egea, M Navío, et al.
Medicina Clinica|September 9, 1989
[Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona]V Soriano, J Tor, A Ribera, et al.
Journal of Viral Hepatitis|August 19, 2014
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patientsD Fuster, A Sanvisens, F Bolao, et al.
Medicina Clinica|March 18, 1995
[Tumor necrosis factor-alpha in human immunodeficiency virus infection]P Llobet, R Muga, J A González, et al.
Current HIV Research|December 29, 2010
Use of highly active antiretroviral therapy is increasing in HIV positive severe drug usersG Vallecillo, A Sanvisens, E Martinez, et al.
Current HIV Research|June 17, 2011
Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug usersA Sanvisens, D Fuster, I Serra, et al.
Medicina Clinica|February 11, 1989
[Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia]V Soriano, J Tor, R Muga, et al.
Medicina Clinica|November 5, 1994
[HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993]R Muga, J M Egea, J Tor, et al.
Medicina Clinica|March 31, 1990
[Primary infection caused by human immunodeficiency virus: clinical and serologic aspects of 7 cases]V Soriano, J Tor, R Muga, et al.
Pageof 5